(Q37929753)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21905784%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

review article

1 reference

title

Impact of HCV genetic differences on pathobiology of disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21905784%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21905784%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Valerio Pazienza

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21905784%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

author name string

Maria Ripoli

series ordinal

1

1 reference

25 August 2017

Valerio Pazienza

series ordinal

2

1 reference

25 August 2017

1 September 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21905784%20AND%20SRC:MED&resulttype=core&format=json

Expert Review of Anti-infective Therapy

12 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21905784%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

volume

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21905784%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21905784%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

page(s)

747-759

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21905784%20AND%20SRC:MED&resulttype=core&format=json

Global epidemiology of hepatitis C virus infection

12 February 2020

cites work

1 reference

Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of the NS-5 region

21 January 2018

1 reference

Full-length sequence of a hepatitis C virus genome having poor homology to reported isolates: comparative study of four distinct genotypes

21 January 2018

1 reference

Genetic diversity and evolution of hepatitis C virus--15 years on

21 January 2018

1 reference

Viral dynamics of hepatitis C early after orthotopic liver transplantation: evidence for rapid turnover of serum virions.

21 January 2018

1 reference

Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-alpha therapy

21 January 2018

1 reference

Hepatitis C viral quasispecies

21 January 2018

1 reference

Viral Determinants of Resistance to Treatment in Patients with Hepatitis C

21 January 2018

1 reference

Genetic diversity of hepatitis C virus predicts recurrent disease after liver transplantation

21 January 2018

1 reference

Development of hepatitis C virus vaccines: challenges and progress.

21 January 2018

1 reference

Hepatitis C virus infection and diabetes: direct involvement of the virus in the development of insulin resistance

21 January 2018

1 reference

Insulin resistance is associated with chronic hepatitis C virus infection and fibrosis progression [corrected].

21 January 2018

1 reference

Risk factors for diabetes mellitus and early insulin resistance in chronic hepatitis C.

21 January 2018

1 reference

Insulin resistance is a cause of steatosis and fibrosis progression in chronic hepatitis C

21 January 2018

1 reference

Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity

21 January 2018

1 reference

Effect of treatment with peginterferon or interferon alfa-2b and ribavirin on steatosis in patients infected with hepatitis C.

21 January 2018

1 reference

Genotype-specific mechanisms for hepatic steatosis in chronic hepatitis C infection.

21 January 2018

1 reference

Different mechanisms of steatosis in hepatitis C virus genotypes 1 and 3 infections

21 January 2018

1 reference

Insulin resistance is associated with steatosis in nondiabetic patients with genotype 1 chronic hepatitis C.

21 January 2018

1 reference

Insulin resistance is associated with liver fibrosis in non-diabetic chronic hepatitis C patients

21 January 2018

1 reference

Insulin resistance in chronic hepatitis C: association with genotypes 1 and 4, serum HCV RNA level, and liver fibrosis

21 January 2018

1 reference

1-Phosphatidylinositol 3-kinase activity is required for insulin-stimulated glucose transport but not for RAS activation in CHO cells

21 January 2018

1 reference

The hepatitis C virus core protein of genotypes 3a and 1b downregulates insulin receptor substrate 1 through genotype-specific mechanisms

21 January 2018

1 reference

Involvement of the PA28 -Dependent Pathway in Insulin Resistance Induced by Hepatitis C Virus Core Protein

21 January 2018

1 reference

Hepatitis C Virus Down-Regulates Insulin Receptor Substrates 1 and 2 through Up-Regulation of Suppressor of Cytokine Signaling 3

21 January 2018

1 reference

SOCS1 and SOCS3 are targeted by hepatitis C virus core/gC1qR ligation to inhibit T-cell function

21 January 2018

1 reference

Non-response to antiviral therapy is associated with obesity and increased hepatic expression of suppressor of cytokine signalling 3 (SOCS-3) in patients with chronic hepatitis C, viral genotype 1

21 January 2018

1 reference

Suppressor of cytokine signaling-3 Provides a novel interface in the cross-talk between angiotensin II and insulin signaling systems

21 January 2018

1 reference

Hepatitis C virus core protein upregulates serine phosphorylation of insulin receptor substrate-1 and impairs the downstream akt/protein kinase B signaling pathway for insulin resistance

21 January 2018

1 reference

Activation of tumor necrosis factor-alpha system in chronic hepatitis C virus infection

21 January 2018

1 reference

Proteasome activator PA28gamma-dependent nuclear retention and degradation of hepatitis C virus core protein

21 January 2018

1 reference

Amino acid substitutions in the hepatitis C virus core region of genotype 1b are the important predictor of severe insulin resistance in patients without cirrhosis and diabetes mellitus.

21 January 2018

1 reference

Impact of amino acid substitutions in the hepatitis C virus genotype 1b core region on liver steatosis and hepatic oxidative stress in patients with chronic hepatitis C.

21 January 2018

1 reference

Amino acid substitutions in the hepatitis C virus core region are the important predictor of hepatocarcinogenesis.

21 January 2018

1 reference

Influence of amino-acid polymorphism in the core protein on progression of liver disease in patients infected with hepatitis C virus genotype 1b.

21 January 2018

1 reference

Mutations in the hepatitis C virus core gene are associated with advanced liver disease and hepatocellular carcinoma

21 January 2018

1 reference

Characteristic mutations in hepatitis C virus core gene related to the occurrence of hepatocellular carcinoma

21 January 2018

1 reference

Hepatic expression of malonyl-CoA decarboxylase reverses muscle, liver and whole-animal insulin resistance

21 January 2018

1 reference

Modulation of insulin activities by leptin

21 January 2018

1 reference

Pioglitazone in chronic hepatitis C not responding to pegylated interferon-alpha and ribavirin

21 January 2018

1 reference

Correction of insulin resistance in chronic hepatitis C patients not responding to the standard of care: more questions than answers

21 January 2018

1 reference

Insulin resistance impairs sustained response rate to peginterferon plus ribavirin in chronic hepatitis C patients.

21 January 2018

1 reference

Hepatitis C virus core protein genotype 3a increases SOCS-7 expression through PPAR-{gamma} in Huh-7 cells

21 January 2018

1 reference

Steatosis and hepatitis C virus: mechanisms and significance for hepatic and extrahepatic disease

21 January 2018

1 reference

Hepatic steatosis in chronic hepatitis C virus infection: prevalence and clinical correlation

21 January 2018

1 reference

Interaction of hepatitis C virus core protein with retinoid X receptor alpha modulates its transcriptional activity

21 January 2018

1 reference

An in vitro model of hepatitis C virus genotype 3a-associated triglycerides accumulation

21 January 2018

1 reference

The genotype 3-specific hepatitis C virus core protein residue phenylalanine 164 increases steatosis in an in vitro cellular model

21 January 2018

1 reference

Morphological changes in intracellular lipid droplets induced by different hepatitis C virus genotype core sequences and relationship with steatosis

21 January 2018

1 reference

Hepatitis C virus core protein shows a cytoplasmic localization and associates to cellular lipid storage droplets

21 January 2018

1 reference

Altered expression patterns of lipid metabolism genes in an animal model of HCV core-related, nonobese, modest hepatic steatosis

21 January 2018

1 reference

Hepatitis C virus core protein inhibits microsomal triglyceride transfer protein activity and very low density lipoprotein secretion: a model of viral-related steatosis

21 January 2018

1 reference

Steatosis and liver cancer in transgenic mice expressing the structural and nonstructural proteins of hepatitis C virus

21 January 2018

1 reference

Hepatitis C virus NS5A colocalizes with the core protein on lipid droplets and interacts with apolipoproteins

21 January 2018

1 reference

Up-regulation of fatty acid synthase promoter by hepatitis C virus core protein: genotype-3a core has a stronger effect than genotype-1b core

21 January 2018

1 reference

HCV core protein induces hepatic lipid accumulation by activating SREBP1 and PPARgamma

21 January 2018

1 reference

Mitochondrial injury, oxidative stress, and antioxidant gene expression are induced by hepatitis C virus core protein

21 January 2018

1 reference

Hepatitis C Virus Induces Proteolytic Cleavage of Sterol Regulatory Element Binding Proteins and Stimulates Their Phosphorylation via Oxidative Stress

21 January 2018

1 reference

The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice

21 January 2018

1 reference

HCV liver infection and liver steatosis: evidence for indirect mechanisms in genotype 3?

21 January 2018

1 reference

The impact of steatosis on disease progression and early and sustained treatment response in chronic hepatitis C patients

21 January 2018

1 reference

Hepatitis C virus genotype 3 is cytopathic to hepatocytes: Reversal of hepatic steatosis after sustained therapeutic response

21 January 2018

1 reference

Hepatocyte steatosis is a cytopathic effect of hepatitis C virus genotype 3.

21 January 2018

1 reference

Worsening of steatosis is an independent factor of fibrosis progression in untreated patients with chronic hepatitis C and paired liver biopsies.

21 January 2018

1 reference

Lipid droplets: a classic organelle with new outfits

21 January 2018

1 reference

The lipid droplet is an important organelle for hepatitis C virus production

21 January 2018

1 reference

Optimization for the detection of hepatitis C virus antigens in the liver

21 January 2018

1 reference

Specific Polymorphisms in Hepatitis C Virus Genotype 3 Core Protein Associated with Intracellular Lipid Accumulation

21 January 2018

1 reference

Mechanisms of liver injury. III. Oxidative stress in the pathogenesis of hepatitis C virus

21 January 2018

1 reference

Different clinical behaviors of acute hepatitis C virus infection are associated with different vigor of the anti-viral cell-mediated immune response

21 January 2018

1 reference

Correlation between virus genotype and chronicity rate in acute hepatitis C.

21 January 2018

1 reference

Severity of liver disease with different hepatitis C viral clones

21 January 2018

1 reference

Worsening of steatosis and fibrosis progression

21 January 2018

1 reference

Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups

21 January 2018

1 reference

Quantification of fibrosis progression in patients with chronic hepatitis C using a Markov model

21 January 2018

1 reference

Contribution of obesity to hepatitis C-related fibrosis progression

21 January 2018

1 reference

Effect of the interaction between steatosis and alcohol intake on liver fibrosis progression in chronic hepatitis C.

21 January 2018

1 reference

Impact of alcohol on the histological and clinical progression of hepatitis C infection.

21 January 2018

1 reference

Interferon therapy in chronic hepatitis C virus: evidence of different outcome with respect to different viral strains.

21 January 2018

1 reference

Hepatitis C genotypes in liver transplant recipients: distribution and 1-year follow-up

21 January 2018

1 reference

Hepatitis C virus genotypes in the United States: epidemiology, pathogenicity, and response to interferon therapy. Collaborative Study Group

21 January 2018

1 reference

Steatosis in chronic hepatitis C: relative contributions of obesity, diabetes mellitus, and alcohol

21 January 2018

1 reference

Genotype 3 is associated with accelerated fibrosis progression in chronic hepatitis C.

21 January 2018

1 reference

Steatosis accelerates fibrosis development over time in hepatitis C virus genotype 3 infected patients

21 January 2018

1 reference

Steatosis affects chronic hepatitis C progression in a genotype specific way

21 January 2018

1 reference

Relationship between steatosis, inflammation, and fibrosis in chronic hepatitis C: a meta-analysis of individual patient data.

21 January 2018

1 reference

Genotype-specific interactions of insulin resistance, steatosis, and fibrosis in chronic hepatitis C.

21 January 2018

1 reference

Expression of cytokines (TNF-alpha, IL-1alpha, and IL-2) in chronic hepatitis C: comparative hybridocytochemical and immunocytochemical study in children and adult patients

21 January 2018

1 reference

Hepatitis C virus genotype 1b as a major risk factor associated with hepatocellular carcinoma in patients with cirrhosis: a seventeen-year prospective cohort study

21 January 2018

1 reference

Hepatitis C virus: molecular biology and genetic variability

21 January 2018

1 reference

Hepatitis C virus genotype 1b as a risk factor for hepatocellular carcinoma development: a meta-analysis

21 January 2018

1 reference

HCV-associated liver cancer without cirrhosis

21 January 2018

1 reference

Hepatitis C prevalence in patients with hepatocellular carcinoma without cirrhosis

21 January 2018

1 reference

Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group

21 January 2018

1 reference

Factors predictive of a beneficial response to therapy of hepatitis C.

21 January 2018

1 reference

Detection of hepatitis C virus by polymerase chain reaction and response to interferon-alpha therapy: relationship to genotypes of hepatitis C virus

21 January 2018

1 reference

Outcome of liver disease in a large cohort of histologically proven chronic hepatitis C: influence of HCV genotype.

21 January 2018

1 reference

Hepatitis C virus 1b(II) infection and development of chronic hepatitis, liver cirrhosis and hepatocellular carcinoma: a case-control study in Japan

21 January 2018

1 reference

Risk of hepatocellular carcinoma and secondary structure of hepatitis C virus (HCV) NS3 protein amino-terminus, in patients infected with HCV subtype 1b.

21 January 2018

1 reference

Complex formation of the nonstructural protein 3 of hepatitis C virus with the p53 tumor suppressor

21 January 2018

1 reference

Microarray analyses and molecular profiling of Stat3 signaling pathway induced by hepatitis C virus core protein in human hepatocytes

21 January 2018

1 reference

Transcriptional regulation of cellular and viral promoters by the hepatitis C virus core protein

21 January 2018

1 reference

Hepatitis C virus core protein activates the MAPK/ERK cascade synergistically with tumor promoter TPA, but not with epidermal growth factor or transforming growth factor alpha

21 January 2018

1 reference

Steatosis, liver injury, and hepatocarcinogenesis in hepatitis C viral infection

21 January 2018

1 reference

Hepatitis C virus core protein downregulates E-cadherin expression via activation of DNA methyltransferase 1 and 3b.

21 January 2018

1 reference

Internal Initiation Stimulates Production of p8 Minicore, a Member of a Newly Discovered Family of Hepatitis C Virus Core Protein Isoforms

21 January 2018

1 reference

Diagnosis, management, and treatment of hepatitis C

21 January 2018

1 reference

Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection

21 January 2018

1 reference

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

21 January 2018

1 reference

Randomised trial of interferon alpha2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. International Hepatitis Interventional Therapy Group (I

21 January 2018

1 reference

Short-term therapy for patients with hepatitis C virus genotype 2 or 3 infection

21 January 2018

1 reference

Peginterferon-alpha-2a (40KD) and ribavirin for 16 or 24 weeks in patients with genotype 2 or 3 chronic hepatitis C.

21 January 2018

1 reference

Prevalence and treatment of hepatitis C virus genotypes 4, 5, and 6.

21 January 2018

1 reference

Diagnosis, management, and treatment of hepatitis C: an update

21 January 2018

1 reference

Occult hepatitis C: how convincing are the current data?

21 January 2018

1 reference

Efficacy and safety of peginterferon alfa-2a (40KD) plus ribavirin in hepatitis C patients with advanced fibrosis and cirrhosis

21 January 2018

1 reference

Peginterferon alfa-2b and ribavirin for the treatment of chronic hepatitis C in blacks and non-Hispanic whites

21 January 2018

1 reference

Peginterferon alpha-2a (40 kDa) and ribavirin: comparable rates of sustained virological response in sub-sets of older and younger HCV genotype 1 patients

21 January 2018

1 reference

Peginterferon and ribavirin treatment in African American and Caucasian American patients with hepatitis C genotype 1.

21 January 2018

1 reference

Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance

21 January 2018

1 reference

IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy

21 January 2018

1 reference

Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C

21 January 2018

1 reference

Relationship of genotype to level of hepatitis C viraemia determined by competitive polymerase chain reaction

21 January 2018

1 reference

Comparison of full-length sequences of interferon-sensitive and resistant hepatitis C virus 1b. Sensitivity to interferon is conferred by amino acid substitutions in the NS5A region

21 January 2018

1 reference

Hepatitis C virus NS5A protein inhibits interferon antiviral activity, but the effects do not correlate with clinical response

21 January 2018

1 reference

Suppression of interferon-induced antiviral activity in cells expressing hepatitis C virus proteins

21 January 2018

1 reference

Prospective characterization of full-length hepatitis C virus NS5A quasispecies during induction and combination antiviral therapy

21 January 2018

1 reference

Evidence that hepatitis C virus resistance to interferon is mediated through repression of the PKR protein kinase by the nonstructural 5A protein

21 January 2018

1 reference

Protein kinases--structure and function.

21 January 2018

1 reference

A template for the protein kinase family

21 January 2018

1 reference

Hepatitis C virus nonstructural 5A protein induces interleukin-8, leading to partial inhibition of the interferon-induced antiviral response

21 January 2018

1 reference

Elevated levels of interleukin-8 in serum are associated with hepatitis C virus infection and resistance to interferon therapy

21 January 2018

1 reference

An altered cellular response to interferon and up-regulation of interleukin-8 induced by the hepatitis C viral protein NS5A uncovered by microarray analysis

21 January 2018

1 reference

The alpha chemokine, interleukin 8, inhibits the antiviral action of interferon alpha

21 January 2018

1 reference

Association of IL28B gene variations with mathematical modeling of viral kinetics in chronic hepatitis C patients with IFN plus ribavirin therapy

21 January 2018

1 reference

Expert opinion on the treatment of patients with chronic hepatitis C

21 January 2018

1 reference

Telaprevir with peginterferon and ribavirin for chronic HCV genotype 1 infection

21 January 2018

1 reference

Telaprevir for previously treated chronic HCV infection

21 January 2018

1 reference

Telaprevir and peginterferon with or without ribavirin for chronic HCV infection

21 January 2018

1 reference

GT-1a or GT-1b Subtype-Specific Resistance Profiles for Hepatitis C Virus Inhibitors Telaprevir and HCV-796

21 January 2018

1 reference

In vitro studies of cross-resistance mutations against two hepatitis C virus serine protease inhibitors, VX-950 and BILN 2061.

21 January 2018

1 reference

Combination of a hepatitis C virus NS3-NS4A protease inhibitor and alpha interferon synergistically inhibits viral RNA replication and facilitates viral RNA clearance in replicon cells

21 January 2018

1 reference

VX-950, a Novel Hepatitis C Virus (HCV) NS3-4A Protease Inhibitor, Exhibits Potent Antiviral Activities in HCV Replicon Cells

21 January 2018

1 reference

SCH 503034, a mechanism-based inhibitor of hepatitis C virus NS3 protease, suppresses polyprotein maturation and enhances the antiviral activity of alpha interferon in replicon cells

21 January 2018

1 reference

Characterization of resistance to the protease inhibitor boceprevir in hepatitis C virus-infected patients

21 January 2018

1 reference

Resistance to direct antiviral agents in patients with hepatitis C virus infection

21 January 2018

1 reference

Identification and analysis of fitness of resistance mutations against the HCV protease inhibitor SCH 503034.

21 January 2018

1 reference

Virologic response rates of weight-based taribavirin versus ribavirin in treatment-naive patients with genotype 1 chronic hepatitis C.

21 January 2018

1 reference

Rapid decline of viral RNA in hepatitis C patients treated with VX-950: a phase Ib, placebo-controlled, randomized study

21 January 2018

1 reference

Treatment failure and resistance with direct-acting antiviral drugs against hepatitis C virus

21 January 2018

1 reference

Crystal structure of the RNA-dependent RNA polymerase from hepatitis C virus reveals a fully encircled active site

21 January 2018

1 reference

The Isomerase Active Site of Cyclophilin A Is Critical for Hepatitis C Virus Replication

21 January 2018

1 reference

The cyclophilin inhibitor Debio-025 shows potent anti-hepatitis C effect in patients coinfected with hepatitis C and human immunodeficiency virus.

21 January 2018

1 reference

The cyclophilin inhibitor Debio 025 combined with PEG IFNalpha2a significantly reduces viral load in treatment-naïve hepatitis C patients.

21 January 2018

1 reference

Clinical trial: randomized, double-blind, placebo-controlled study of nitazoxanide monotherapy for the treatment of patients with chronic hepatitis C genotype 4.

21 January 2018

1 reference

Potential for Hepatitis C Virus Resistance to Nitazoxanide or Tizoxanide

21 January 2018

1 reference

Characterization of host-range and cell entry properties of the major genotypes and subtypes of hepatitis C virus

21 January 2018

1 reference

Distribution of hepatitis C virus genotypes in German patients with chronic hepatitis C: correlation with clinical and virological parameters.

21 January 2018

1 reference

Relationship between hepatitis C virus genotypes and sources of infection in patients with chronic hepatitis C.

21 January 2018

1 reference

Hepatitis C virus: epidemiology and genotypes in the north east of England.

21 January 2018

1 reference

Gene expression profile of Huh-7 cells expressing hepatitis C virus genotype 1b or 3a core proteins

21 January 2018

1 reference

Epidemiology of hepatitis C: geographic differences and temporal trends

21 January 2018

1 reference

Direct-acting antiviral therapy for hepatitis C: attitudes regarding future use.

21 January 2018

1 reference

Review article: specifically targeted anti-viral therapy for hepatitis C - a new era in therapy

21 January 2018

1 reference

Antiviral suppression vs restoration of RIG-I signaling by hepatitis C protease and polymerase inhibitors

21 January 2018

1 reference

Therapeutic implications of hepatitis C virus resistance to antiviral drugs

21 January 2018

1 reference

Telaprevir and pegylated interferon-alpha-2a inhibit wild-type and resistant genotype 1 hepatitis C virus replication in patients

21 January 2018

1 reference

Dynamic hepatitis C virus genotypic and phenotypic changes in patients treated with the protease inhibitor telaprevir

21 January 2018

1 reference

The culture of designing hepato-biliary randomised trials

21 January 2018

1 reference

Hepatitis C Virus (HCV) Genotype 1 Subtype Identification in New HCV Drug Development and Future Clinical Practice

21 January 2018

1 reference

Hepatitis C virus protein expression causes calcium-mediated mitochondrial bioenergetic dysfunction and nitro-oxidative stress

21 January 2018

1 reference

Vitamin D deficiency and a CYP27B1-1260 promoter polymorphism are associated with chronic hepatitis C and poor response to interferon-alfa based therapy

21 January 2018

1 reference

Low vitamin D serum level is related to severe fibrosis and low responsiveness to interferon-based therapy in genotype 1 chronic hepatitis C.

21 January 2018

1 reference

Hepatoprotective effects of antioxidants in chronic hepatitis C.

21 January 2018

1 reference

An antioxidant resveratrol significantly enhanced replication of hepatitis C virus

21 January 2018

1 reference

Histopathology of hepatitis C virus infection

21 January 2018

1 reference

Detection of hepatitis C virus antigen by immuno-histochemical staining: a histological marker of hepatitis C virus infection

21 January 2018

1 reference

Activation of the Ras Mitogen-activated Protein Kinase-Ribosomal Protein Kinase Pathway Is Not Required for the Repression of Phosphoenolpyruvate Carboxykinase Gene Transcription by Insulin

21 January 2018

1 reference

Insulin rapidly stimulates tyrosine phosphorylation of a Mr-185,000 protein in intact cells

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1586/ERI.11.94

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21905784%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

1 reference